DHT plays a central role in the pathogenesis of benign prostatic hyperplasia (BPH) by continuously activating the androgen receptor signaling pathway and promoting the proliferation of prostate epithelial cells (Wang et al., 2017). This evidence concerns the gene AR and benign prostatic hyperplasia.